ClinicalTrials.gov
public full text
Public Domain
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
This study evaluates the safety and efficacy of long-term on-demand treatment with orally administered deucrictibant for acute hereditary angioedema (HAE) attacks, including laryngeal attacks. The study will enroll participants from Study PHA022121-C201 (NCT04618211), Study PHA022121-C306 (NCT06343779) and deucrictibant treatment naïve HAE-nC1INH adult participants who elect to participate in this extension study and meet the eligibility requirements.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks#839829
- Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity#883678
- A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma#195310
- A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma#268033
- Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839#871523
Record · ID 1139533
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive